Top of the morning to you, and a fine one it is. Clear blue skies are enveloping the Pharmalot campus this morning, where the official mascots are enjoying the tundra-like grounds and we are brewing yet another cup of stimulation. Our choice today, for those who track this sort of thing, is hot buttery rum. As always, you are invited to join us. Meanwhile, we have assembled the latest menu of tidbits for you to peruse as you get started on your journey today. We wish you the best of luck and, of course, do keep in touch. The inbox is open …

The Food and Drug Administration informed senior executives at Merck, Sanofi, and AstraZeneca last week that their approved protective RSV treatments for infants would be subject to fresh safety scrutiny following concerns raised by vaccine skeptics ,

See Full Page